Real-World Effectiveness of Nirsevimab Against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants

NCT07382219 · clinicaltrials.gov ↗

COMPLETED

Status

816

Enrollment

OTHER

Sponsor class

Conditions

RSV Infections
Lower Respiratory Tract Infections

Interventions

BIOLOGICAL: Nirsevimab

Sponsor

Han Tongyan